REG - Dr. Martens PLC - Annual Financial Report

Dr MartensAnnouncement

12/06/2024 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240612:nRSL1266Sa&default-theme=true

RNS Number : 1266S  Dr. Martens PLC  12 June 2024

Dr. Martens plc (the "Company")

2024 Annual Report and Notice of Annual General Meeting

Further to the announcement of its preliminary results for the financial year
ended 31 March 2024 and in accordance with Listing Rule 9.6.1, the Company
announces that the following documents have been submitted in unedited full
text to the National Storage Mechanism and will be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism:

·      Annual Report and Accounts for the financial year ended 31 March
2024 (the "2024 Annual Report")

·      Notice of the 2024 Annual General Meeting (the "2024 Notice of
Meeting"), which will take place at 9.30am on Thursday 11 July 2024 at Holiday
Inn London - Camden Lock, 30 Jamestown Road, Camden, London, NW1 7BY

·      Proxy form for the 2024 Annual General Meeting

In compliance with rule 6.3.5R of the Disclosure Guidance and Transparency
Rules, the 2024 Annual Report and 2024 Notice of Meeting are also available in
unedited full text on the Company's website, www.drmartensplc.com.

For further information, please contact:

Paul Rolling, Assistant Company Secretary

+447584243562

Bethany Barnes, Director of Investor Relations

+447825187465

ENDS

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Produced originally for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class roots while
still celebrating its proud heritage and, six decades later, "Docs" or "DM's"
are worn by people around the world who use them as a symbol of empowerment
and their own individual attitude. The Company is a constituent of the FTSE
250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSGPUWPQUPCUMP